GLP-1 receptor agonist
Exenatide dose
Answer
Half-life on the label: 2.4 hours. Trials with posted results tested 7 doses, most often 5 mcg, 10 mcg, 2 mg.
Not dosing advice.
FDA LABEL
What the approved labels state
Exenatide ANDA206697 · label of 2026-05-27 Regulator
Half-life: 2.4 hours (section 12.3).
Byetta NDA021773 · label of 2025-09-02 Regulator
Half-life: 2.4 hours (section 12.3).
IN TRIALS
Doses tested in 128 trials with posted results
| Dose in the arm title | Trials | People on it | Phases |
|---|---|---|---|
| 5 mcg | 2 | 113 | 3 |
| 10 mcg | 2 | 109 | 3 |
| 2 mg | 2 | 53 | 1/2 |
| 8 mg | 1 | 31 | 2 |
| 10 mg | 1 | 30 | 1/2 |
| 11 mg | 1 | 30 | 2 |
| 5 mg | 1 | 30 | 2 |
Trial register Read from the titles of arms that received Exenatide (n ≥ 20). An arm naming several doses counts under each; a schedule or escalation is on the trial record. All trials.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.